A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors (Q84265156)
Jump to navigation
Jump to search
scientific article published on 03 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors |
scientific article published on 03 June 2011 |
Statements
A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors (English)
J R Infante
R Kurzrock
J Spratlin
H A Burris
S G Eckhardt
J Li
K Wu
J M Skolnik
L Hylander-Gans
A Osmukhina
D Huszar